Regarding hypoglycemics, biguanides were the most commonly prescribed at admission, followed by SGLT-2 inhibitors and GLP-1 receptor agonists, in accordance with ADA guidelines for T2DM management [20]. Here, GLP1R is linked to type 2 diabetes mellitus.